There are 3484 resources available
Three ways EC management is changing
Presenter: Christian Marth
Session: GSK - The breakthrough era in endometrial cancer treatment
Resources:
Webcast
Welcome and introduction
Presenter: Enriqueta Felip
Session: ESMO Colloquium supported by Daiichi Sankyo, Europe in collaboration with AstraZeneca: The impact of antibody-drug conjugates (ADCs) in the changing treatment landscape of advanced NSCLC
Resources:
Slides
Webcast
Resilience is key after diagnosis, during treatment, and after treatment
Presenter: Natacha Bolanos Fernandez
Session: Living with and after cancer
Resources:
Slides
Webcast
Behavioural changes in daily life: A cross-cutting approach for daily wellbeing
Presenter: Joanna Kufel-Grabowska
Session: Living with and after cancer
Resources:
Slides
Webcast
Strategies for overcoming EGFR resistance in NSCLC patient management
Presenter: Antonio Passaro
Session: Janssen Pharmaceutica N.V. - Transforming treatment approaches for patients with EGFR-mutant NSCLC
Resources:
Webcast
Reinforcing standard of care: The benefits of early treatment intensification in patients with mHSPC
Presenter: All Speakers
Session: Astellas Pharma Europe Ltd - Putting the patient first: Considering treatment choice and maximising quality of life in mHSPC
Resources:
Webcast
Anti–PD-(L)1s plus chemotherapies continue to evolve: Updates from 2023 congresses
Presenter: Ilaria Colombo
Session: GSK - The breakthrough era in endometrial cancer treatment
Resources:
Webcast
Emerging data on the role of ADCs in the clinical care pathways for advanced NSCLC patients
Presenter: Pasi Jänne
Session: ESMO Colloquium supported by Daiichi Sankyo, Europe in collaboration with AstraZeneca: The impact of antibody-drug conjugates (ADCs) in the changing treatment landscape of advanced NSCLC
Resources:
Slides
Webcast
Synergy: Is it more than a buzzword for IO plus PARPi or TKI?
Presenter: Kathleen Moore
Session: GSK - The breakthrough era in endometrial cancer treatment
Resources:
Webcast
The importance of first-line treatment choice in patients with mHSPC
Presenter: All Speakers
Session: Astellas Pharma Europe Ltd - Putting the patient first: Considering treatment choice and maximising quality of life in mHSPC
Resources:
Webcast